LAS VEGAS, April 29, 2025 /PRNewswire/ -- DelveInsight's "FABHALTA Market Size, Forecast, and Market Insight Report" highlights the details around FABHALTA, an oral complement factor B inhibitor used ...
With future approvals of FABHALTA, the market size is expected to expand significantly in the coming years, driven by its potential to address unmet medical needs across multiple conditions like IgAN, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results